Diagnosis and treatment of metastatic and castration resistant prostate cancer became more and more and complex due to the increasing knowledge and understanding of the underlying molecular events and the subsequently deducted innovative medical treatment
Modern imaging studies in CRPCA have become more and more complex and selective and currently include positron emission tomography, whole body magnetic resonance imaging, immunoscintigraphy besides the traditional studies such as bone scans and computed tomography.
About the Editors
Kurt Miller MD, PhD
Professor Miller has been Chairman and Professor of Urology for the Department of Urology at the Benjamin Franklin Medical Center, Berlin, Germany, since 1993. In 2007 he became Chairman of the ...
Read more »
Axel Merseburger MD, PhD
Prof Axel S. Merseburger is currently Vice Chairman of the Department of Urologic Oncology, as well as Director of the Urologic Oncology Programme at Hannover Medical School, Germany. ...
Read more »
21 August - 23 August
7th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer
Pasadena, CA, USA
Contact: Erasmus S.A.
Tel.: +30 210 7414718
Fax: +30 210 7257532
28 August - 30 August
3rd International Neuro-Urology Meeting
Contact: Swiss Continence Foundation
Tel.: +41 61 9217174
Fax: +41 61 9217176
31 August - 2 September
15th Asia-Pacifi c Prostate Cancer Conference 2014
Contact: Australian Prostate Cancer Research
Tel.: +61 1300 792 466
Fax: +61 3 9818 7111